8-K
filed May 2, 2024, 7:59 PM ET
ticker GCTK
CIK 0001506983
other material
confidence high
sentiment neutral
materiality 0.55
Glucotrack stockholders approve reverse stock split and 2024 equity plan
Glucotrack, Inc.
- Approved reverse stock split ratio of 1:5 to 1:30, timing at Board's discretion (17.1M for, 0.78M against).
- Approved 2024 Equity Incentive Plan (9.99M for, 0.89M against, 5.16M abstentions).
- Re-elected six directors: Fischell, Malave, Sycoff, Rapps, Danzig, Carter for one-year terms.
- Ratified Fahn Kanne & Co. as independent auditor for fiscal 2023 (17.8M for, 0.11M against).
- Advisory vote on executive compensation will be held every three years based on stockholder preference.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Glucotrack, Inc. shareholders approved Reverse Stock Split at the 2024-04-26 meeting.
- Proposal
- reverse split
- Outcome
- passed
- Meeting
- 2024-04-26
Exact text from the filing
Proposal 3 – Reverse Stock Split The Company’s stockholders approved of an amendment to Article IV of the Company’s Certificate of Incorporation
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Glucotrack, Inc. shareholders approved Election of Directors at the 2024-04-26 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2024-04-26
Exact text from the filing
The final results of the voting were as follows: Director Votes For Votes Against Abstentions Broker Non-Vote Dr. Robert Fischell 10,793,666 134,682 5,109,423 1,932,226 Luis Malave 10,793,666 122,745 5,121,360 1,932,226 Andrew Sycoff 10,805,663 5,231,471 637 1,932,226 Shimon Rapps 10,786,853 5,231,531 19,387 1,932,226 Allen Danzig 10,793,726 122,685 5,121,360 1,932,226 Erin Carter 10,793,806 122,745 5,121,220 1,932,226
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.7
Glucotrack, Inc. shareholders voted on Frequency of Non-Binding Advisory Votes on Executive Compensation at the 2024-04-26 meeting.
- Proposal
- say on pay frequency
- Meeting
- 2024-04-26
Exact text from the filing
Proposal 5 – Frequency of Non-Binding Advisory Votes on Executive Compensation The Company’s stockholders indicated, on an advisory basis, the preferred frequency of future non-binding advisory votes on the compensation of the Company’s named executive officers as follows: Every One (1) Year Every Two (2) Years Every Three (3) Years Abstentions 2,213,593 531,688 8,138,410 5,154,080
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Glucotrack, Inc. shareholders approved 2024 Equity Incentive Plan at the 2024-04-26 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2024-04-26
Exact text from the filing
Proposal 1 – 2024 Equity Incentive Plan The Company’s 2024 Equity Incentive Plan was approved. The final results of the voting were as follows: Votes For Votes Against Abstentions Broker Non-Votes 9,989,257 885,365 5,163,149 1,932,226
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Glucotrack, Inc. shareholders approved Ratification of Independent Registered Public Accountant at the 2024-04-26 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2024-04-26
Exact text from the filing
Proposal 4 – Ratification of Independent Registered Public Accountant The Company’s stockholders ratified the previous appointment by the Audit Committee of the Board of Fahn Kanne & Co
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.